Well Lead Medical (603309.SH) has obtained the registration certificate for Class II medical devices for "disposable hydrophilic coated visual nasal gastroenteric tube."
Weilai Medical (603309.SH) announced that its wholly-owned subsidiary, Hainan Weilai Medical Technology Development Co., Ltd...
Well Lead Medical (603309.SH) announced that its wholly-owned subsidiary, Hainan Well Lead Medical Technology Development Co., Ltd. ("Hainan Well Lead"), recently received the "Medical Device Registration Certificate of the People's Republic of China" from the Hainan Provincial Food and Drug Administration. The registered product is the "disposable hydrophilic-coated visual nasal-gastric tube."
The acquisition of the above medical device registration certificate by the subsidiary Hainan Well Lead will help diversify the product offerings of the subsidiary and enhance the market competitiveness of the company's products. This development will have a positive impact on the company's operations.
Related Articles

SOUTH MANGANESE (01091) intends to discount approximately 18.55% for the sale of up to 823 million shares, with a net raise of approximately HK$180 million.

Huizhou Speed Wireless Technology (300322.SZ) plans to repurchase shares worth 20 to 30 million yuan.

TIANGONG INT'L(00826): TGGF appoints Chu Mingfan as securities affairs representative.
SOUTH MANGANESE (01091) intends to discount approximately 18.55% for the sale of up to 823 million shares, with a net raise of approximately HK$180 million.

Huizhou Speed Wireless Technology (300322.SZ) plans to repurchase shares worth 20 to 30 million yuan.

TIANGONG INT'L(00826): TGGF appoints Chu Mingfan as securities affairs representative.

RECOMMEND

Li Ning Faces Sharp Decline in Market Value Amid Strategic Uncertainty and Brand Challenges
08/07/2025

First Batch of Copper Arrives in Hong Kong Warehouses, to Join LME Global Storage Network
08/07/2025

NDRC and Three Departments Jointly Issue Notice to Advance Grid Construction and High-Power Charging Infrastructure Development
08/07/2025